Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to 0.33.

  • Arcturus Therapeutics Holdings' Asset Utilization Ratio fell 2190.88% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 2190.88%. This contributed to the annual value of 0.39 for FY2024, which is 386.51% up from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Asset Utilization Ratio of 0.33 as of Q3 2025, which was down 2190.88% from 0.38 recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' Asset Utilization Ratio's 5-year high stood at 0.67 during Q3 2023, with a 5-year trough of 0.02 in Q2 2021.
  • Over the past 5 years, Arcturus Therapeutics Holdings' median Asset Utilization Ratio value was 0.38 (recorded in 2023), while the average stood at 0.31.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Asset Utilization Ratio tumbled by 9238.97% in 2021 and then surged by 175348.87% in 2022.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Asset Utilization Ratio (Quarter) stood at 0.03 in 2021, then surged by 1753.49% to 0.55 in 2022, then plummeted by 32.09% to 0.38 in 2023, then grew by 13.33% to 0.43 in 2024, then dropped by 22.59% to 0.33 in 2025.
  • Its Asset Utilization Ratio stands at 0.33 for Q3 2025, versus 0.38 for Q2 2025 and 0.43 for Q1 2025.